Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
135.42
-4.37 (-3.13%)
BSENSE

Dec 05

BSE+NSE Vol: 1.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jenburkt Pharma
Medicamen Biotec
Kilitch Drugs
Fermenta Biotec.
Anuh Pharma
Kopran
Shree Ganesh Rem
Ind-Swift Labs.
Bharat Parenter.
Anlon Healthcare
Influx Health.
Why is Kopran Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -11.79% of over the last 5 years
2
With a fall in Net Sales of -22.2%, the company declared Very Negative results in Sep 25
  • The company has declared negative results for the last 5 consecutive quarters
  • The company has declared negative results in Sep 24 after 4 consecutive negative quarters
  • PAT(Q) At Rs -9.92 cr has Fallen at -234.4%
  • ROCE(HY) Lowest at 5.38%
  • OPERATING PROFIT TO INTEREST (Q) Lowest at -2.53 times
3
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
4
Below par performance in long term as well as near term
  • Along with generating -36.70% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kopran for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kopran
-36.5%
-0.90
40.53%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.72%
EBIT Growth (5y)
-11.79%
EBIT to Interest (avg)
8.24
Debt to EBITDA (avg)
1.59
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
1.09
Tax Ratio
31.86%
Dividend Payout Ratio
37.57%
Pledged Shares
0
Institutional Holding
0.60%
ROCE (avg)
12.29%
ROE (avg)
10.74%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
37
Industry P/E
34
Price to Book Value
1.30
EV to EBIT
26.27
EV to EBITDA
16.85
EV to Capital Employed
1.24
EV to Sales
1.30
PEG Ratio
NA
Dividend Yield
2.22%
ROCE (Latest)
4.73%
ROE (Latest)
3.51%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 37.14 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 3.66 times

-25What is not working for the Company
PAT(Q)

At Rs -9.92 cr has Fallen at -234.4%

ROCE(HY)

Lowest at 5.38%

OPERATING PROFIT TO INTEREST (Q)

Lowest at -2.53 times

DEBT-EQUITY RATIO(HY)

Highest at 0.31 times

NET SALES(Q)

Lowest at Rs 117.91 cr

PBDIT(Q)

Lowest at Rs -5.28 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -4.48%

PBT LESS OI(Q)

Lowest at Rs -11.66 cr.

EPS(Q)

Lowest at Rs -2.05

Loading Valuation Snapshot...
Here's what is working for Kopran
Cash and Cash Equivalents - Half Yearly
Highest at Rs 37.14 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 3.66 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Kopran
Net Sales - Quarterly
At Rs 117.91 cr has Fallen at -22.20%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -11.66 cr has Fallen at -234.95%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -9.92 cr has Fallen at -234.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Lowest at -2.53 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales - Quarterly
Lowest at Rs 117.91 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -5.28 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -4.48%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -11.66 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -2.05
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Highest at 0.31 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio